A constitutively active human NRAS oncogene (G12V NRAS, pT/Caggs-V12Nras, 25 μg) was injected into C57BL/6J p19Arf-null mice, and mice developed mixed HCC/iCCA 4–6 weeks after injection (73). Here, NRAS is linked to hepatocellular carcinoma.